Challenge of evidence in individualized medicine

Personalized Medicine
Kathleen Kraft, Wolfgang Hoffmann

Abstract

Tension between standardization and individualization has always been a characteristic of medical activity. However, whether it is better that interventions should be based on guideline recommendations on the basis of large multicenter trials, or on a genetic biomarker in individualized medicine, can be the subject of debate. With the aid of stratification, evidence-based medicine and individualized medicine could be linked. Networks of large research projects, involving clinical, biomedical, molecular and other expertises are necessary for evidence-based evaluation, standardization, and clinical validation of new methods and algorithms.

References

Jan 13, 1996·BMJ : British Medical Journal·D L SackettW S Richardson
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V R GrannA I Neugut
Oct 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Z M YounossiK M Shermock
Aug 11, 2005·JAMA : the Journal of the American Medical Association·Cynthia M BoydAlbert W Wu
Nov 29, 2007·The British Journal of Nutrition·Michael R LoweKaren Miller-Kovach
Feb 8, 2008·The New England Journal of Medicine·Simon MallalUNKNOWN PREDICT-1 Study Team
Jun 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hugues de LavalladeDavid Marin
Mar 21, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jaekyu ShinTaimour Y Langaee
Oct 10, 2009·Health Policy·Lisa M Meckley, Peter J Neumann
Nov 17, 2009·Medizinische Klinik·Thomas Seufferlein, Guido Adler
Apr 13, 2010·Journal of the American College of Cardiology·Robert S EpsteinJ Russell Teagarden
May 14, 2010·Future Cardiology·Richard L SeipGualberto Ruaño
Jun 17, 2010·The New England Journal of Medicine·Margaret A Hamburg, Francis S Collins
Aug 10, 2010·Molecular Cancer Research : MCR·Maria DiamandisGeorge M Yousef
Dec 15, 2010·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Bärbel Hüsing
Jan 14, 2011·Nature·George Poste
Jan 29, 2011·Journal of the American College of Cardiology·Brian S FinkelmanStephen E Kimmel
Apr 13, 2011·British Journal of Clinical Pharmacology·Mas Chaponda, Munir Pirmohamed
Jun 28, 2011·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Se-Won OhJee-In Hwang
Sep 9, 2011·Neurosurgery·Rudy J RahmeBernard R Bendok
Mar 1, 2011·Personalized Medicine·Wolfgang HoffmannHeyo K Kroemer

❮ Previous
Next ❯

Citations

Apr 25, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·B BrüggenjürgenS N Willich
Dec 2, 2015·Genome Génome / Conseil National De Recherches Canada·Naazish S Bashir, Wendy J Ungar

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

Optifast

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.